EDGAR Filing Documents for 0001493152-24-007928

Form 8-K - Current report:

SEC Accession No. 0001493152-24-007928

Filing Date

2024-02-27

Accepted

2024-02-27 07:00:05

Documents

Period of Report

2024-02-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	48954
2		ex10-1.htm	EX-10.1	304568
3		ex10-2.htm	EX-10.2	171915
4		ex10-3.htm	EX-10.3	126170
5		ex10-1_001.jpg	GRAPHIC	10003
	Complete submission text file	0001493152-24-007928.txt		967935

Data Files

Seq	Description	Document	Type	Size
6	INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	qlgn-20240225.xsd	EX-101.SCH	3009
7	INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	qlgn-20240225_lab.xml	EX-101.LAB	34240
8	INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	qlgn-20240225_pre.xml	EX-101.PRE	22355
19	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3622

Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011

Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165

Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)